top of page



  • EUD-GK-91 has succesfully reached PoC in NSCLC Tumour Cells


  • EUD-GK-91 shows a preferential and significant inhibition of the gatekeeper resistant mutation


  • EUD-GK-91 has a good selectivity profile with low effect on normal cells

  • Eudendron has developed novel molecular designs to generate compounds successfully inhibiting kinase mutated forms


  • EUD-GK-91 is a novel compound designed and prepared by Eudendron to provide an effective and promising answer to drug resistance in NSCLC treatment

bottom of page